Media
Media
Our latest announcements
Hansa Biopharma Report First Quarter 2026 Financial Results
Regulatory press release
23/04/2026
Hansa Biopharma to host Q1 2026 interim results conference call
08/04/2026
Hansa Biopharma publishes 2025 Annual and Sustainability Reports
Regulatory press release
26/03/2026
Hansa Biopharma announces a USD 30 million convertible note financing
Regulatory press release
20/03/2026
Media articles
Insights
The Power of Hope: Redefining Treatment Decisions for Highly Sensitized Kidney Patients
07/08/2025
Collaboration across the continuum of care to improve equity for highly sensitized people in kidney transplantation
17/07/2024
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Patients' perspective
Life on tour with chronic kidney disease
“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Patients' perspective
Suspended time: a journey from diagnosis to transplant
"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
